Definitive Contract W81XWH16C0080
Award Date
9/8/16
Potential Completion Date
4/7/17
Potential Value
$150K
Federal Agency
Medical Command
Awardee
Cytosorbents Medical Inc.
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC Category
AN91 - R&D- Medical: Other (Basic Research)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Monmouth Junction, South Brunswick Township, NJ 08852, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
135
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a $149,979 firm-fixed-price Definitive Contract awarded by the United States Army Medical Command (MEDCOM) to Cytosorbents Medical Inc., a small business manufacturer of medical devices and technologies. The contract was awarded under the Small Business Innovation Research (STTR) program for Phase I research, with the goal of developing an extracorporeal cytokine adsorber to treat septic shock. As a small business, this contract award was set aside for Cytosorbents as the prime...
This contract was awarded by the Department of the Army Medical Command to Cytosorbents Medical Inc., doing business as Cytosorbents, a for-profit small business manufacturer of medical devices and technologies. The $999,871.34 fixed-price level of effort contract is for Phase II of a Small Business Innovation Research (SBIR) project to develop blood purification technologies. Cytosorbents, as the prime contractor, is providing research and prototype development services to the Defense Health...
Cytosorbents Medical Inc., doing business as Cytosorbents, was awarded a $999,070.00 Small Business Innovation Research (SBIR) Phase II contract by the Department of the Army Medical Command. The contract is for the development of medical devices and technologies, including an extracorporeal cytokine adsorber to treat septic shock, a potassium adsorber to treat hyperkalemia, and an adsorber to remove anti-A and anti-B antibodies from blood for transfusion. Cytosorbents is the prime contractor...
This is a $999,996.59 firm-fixed-price Phase II SBIR contract awarded by the Joint PEO Chemical and Biological Defense to Cytosorbents Medical Inc., a small business manufacturer of medical devices and technologies. The contract is for research and prototype development services related to Cytosorbents' blood purification technologies, including an extracorporeal cytokine adsorber, a potassium adsorber, and a blood group antibody adsorber. These technologies are intended to treat critical care...
Cytosorbents Medical Inc., doing business as Cytosorbents and classified as a small disadvantaged business, has been awarded a $74,918 firm fixed price purchase order by the Department of the Air Force Materiel Command Research Laboratory. The contract is set aside for total small business and involves research and development of a novel sorbent technology for the rapid treatment of acute joint injury and inflammation under the Small Business Innovation Research Program Phase I. Work will be...
The Department of the Army Medical Command awarded a $4.3 million firm fixed price Small Business Innovation Research Program Phase III research and development contract to Cytosorbents Medical Inc., doing business as Cytosorbents, for integrating isoagglutinin reduction for a universal dried plasma product for battlefield and first responder use. Cytosorbents Corporation, doing business as Cytosorbents, is the parent company of the prime contractor Cytosorbents Medical Inc. The work will be...
This is a $1,499,987.16 Firm Fixed Price Definitive Contract awarded by the U.S. Army Medical Command (MEDCOM) to Cytosorbents Medical Inc., a small business manufacturer, under the Small Business Innovation Research (SBIR) program. The contract is for medical research and development to investigate a potassium adsorber for treating hyperkalemia resulting from traumatic injury and acute kidney injury in austere environments. This is a Phase II SBIR action with a completion date of February 20,...
This $1.1 million firm fixed price contract was awarded by the Department of the Army Medical Command to Cytosorbents Medical Inc., doing business as Cytosorbents, to support research and development of an adsorber to remove anti-A and anti-B antibodies from plasma for transfusion under the Small Business Innovation Research (SBIR) Program Phase II solicitation. As a total small business set-aside, the contract aims to further the prime contractor's development of an effective adsorber that...
This is a $9,050,674.00 definitive cost-sharing contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Cytovale Inc., a self-certified small disadvantaged business. The contract is for advancing Cytovale's biophysical early sepsis diagnostic towards U.S. Food and Drug Administration (FDA) 510(k) clearance. This contract was awarded under a Broad Agency Announcement (BAA) from the Biomedical Advanced Research...
This is a Definitive Contract award under the Small Business Innovation Research (SBIR) program, issued by the U.S. Army's Medical Command (MEDCOM) to CFD Research Corporation, a small business based in Huntsville, Alabama. The $1,499,996.35 contract is for a Sequential Phase II effort titled "Producing Biosynthetic Therapeutics from Extreme Microbiomes" to develop medical R&D related to COVID-19. This award is set aside for small businesses. CFD Research has a history of receiving...